Wasim Muhammad, Khan Haq Nawaz, Ayesha Hina, Goorden Susanna M I, Vaz Frederic M, van Karnebeek Clara D M, Awan Fazli Rabbi
Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
Pakistan Institute of Engineering and Applied Sciences, Islamabad, Pakistan.
Front Neurol. 2019 Jul 17;10:762. doi: 10.3389/fneur.2019.00762. eCollection 2019.
Inborn errors of metabolism (IEMs) are rare group of genetic disorders comprising of more than 1,000 different types. Around 200 of IEMs are potentially treatable through diet, pharmacological and other therapies, if diagnosed earlier in life. IEMs can be diagnosed early through newborn screening (NBS) programs, which are in place in most of the developed countries. However, establishing a NBS in a developing country is a challenging task due to scarcity of disease related data, large population size, poor economy, and burden of other common disorders. Since, not enough data is available for the prevalence of IEMs in Pakistan; therefore, in this study, we set out to find the prevalence of various treatable IEMs in a cohort of intellectually disabled patients suspected for IEMs, which will help us to initiate a NBS program for the most frequent IEMs in Pakistan. Therefore, a total of 429 intellectually disabled (IQ <70) patient samples were collected from Pakistan. A subset of 113 patient samples was selected based on the clinical information for the detailed biochemical screening. Advance analytical techniques like, Amino Acid Analyzer, GC-MS, UHPLC-MS, and MS/MS were used to screen for different treatable IEMs like aminoacidopathies, fatty acid β-oxidation disorders and mucopolysaccharidoses (MPS) etc. A total of 14 patients were diagnosed with an IEM i.e., 9 with homocystinuria, 2 with MPS, 2 with Guanidinoacetate methyltransferase (GAMT) deficiency and 1 with sitosterolemia. These IEMs are found frequent in the collected patient samples from Pakistan. Thus, present study can help to take an initiative step to start a NBS program in Pakistan, especially for the homocystinuria having highest incidence among aminoacidopathies in the studied patients, and which is amenable to treatment. This endeavor will pave the way for a healthier life of affected patients and will lessen the burden on their families and society.
先天性代谢缺陷(IEMs)是一类罕见的遗传性疾病,包括1000多种不同类型。如果在生命早期得到诊断,约200种IEMs可通过饮食、药物和其他疗法进行治疗。IEMs可通过新生儿筛查(NBS)项目早期诊断,大多数发达国家都有该项目。然而,在发展中国家建立NBS是一项具有挑战性的任务,原因包括疾病相关数据匮乏、人口规模大、经济落后以及其他常见疾病的负担。由于巴基斯坦IEMs患病率的数据不足,因此在本研究中,我们着手在一组疑似患有IEMs的智力残疾患者中寻找各种可治疗的IEMs的患病率,这将有助于我们在巴基斯坦启动针对最常见IEMs的NBS项目。因此,我们从巴基斯坦共收集了429份智力残疾(智商<70)患者样本。根据临床信息选择了113份患者样本进行详细的生化筛查。使用氨基酸分析仪、气相色谱-质谱联用仪、超高效液相色谱-质谱联用仪和串联质谱等先进分析技术,筛查不同的可治疗IEMs,如氨基酸病、脂肪酸β-氧化障碍和黏多糖贮积症(MPS)等。共有14名患者被诊断患有IEMs,即9名患有同型胱氨酸尿症,2名患有MPS,2名患有胍基乙酸甲基转移酶(GAMT)缺乏症,1名患有谷甾醇血症。这些IEMs在从巴基斯坦收集的患者样本中较为常见。因此,本研究有助于采取主动措施在巴基斯坦启动NBS项目,特别是针对在所研究患者的氨基酸病中发病率最高且可治疗的同型胱氨酸尿症。这一努力将为受影响患者的健康生活铺平道路,并减轻其家庭和社会的负担。